Quillivant XR 300 mg/60mL (Methylphenidate Hydrochloride SUSPENSION, EXTENDED RELEASE) 300 mg/60mL

Quillivant XR 300 mg/60mL is an extended-release oral suspension containing methylphenidate hydrochloride. It is commonly used for attention deficit hyperactivity disorder (ADHD) management. This medication helps improve focus and impulse control.

Strength

300 mg/60mL

Pack Size

1 BOTTLE in 1 CARTON (24478-321-02) / 60 mL in 1 BOTTLE

Manufacturer / TM Owner

NextWave Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Quillivant XR 300 mg/60mL is primarily used for the treatment of ADHD in patients who require extended-release medication. It is designed to provide a steady release of methylphenidate hydrochloride throughout the day, helping to manage symptoms such as inattention, hyperactivity, and impulsivity. This medication is often prescribed to improve focus and impulse control in individuals with ADHD.

Side Effects

Common effects of Quillivant XR 300 mg/60mL may include decreased appetite, trouble sleeping, and mild stomach upset. Some users may experience increased heart rate or blood pressure. It is important to monitor for any unusual or severe side effects and consult a healthcare provider if they occur.

Precautions & Warnings

Quillivant XR 300 mg/60mL should be stored at room temperature and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the medication, as it is designed for oral suspension.

Avoid Interactions

Quillivant XR 300 mg/60mL may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), antidepressants, and blood pressure medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, consuming alcohol while taking this medication should be avoided.

Frequently Asked Questions

Quillivant XR 300 mg/60mL is used for the treatment of ADHD in patients who require extended-release medication.

Quillivant XR 300 mg/60mL should be taken orally as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions.

Common side effects may include decreased appetite, trouble sleeping, and mild stomach upset. Some users may experience increased heart rate or blood pressure.

Quillivant XR 300 mg/60mL may interact with certain medications, so it is important to inform your healthcare provider about all medications you are taking.

Consuming alcohol while taking Quillivant XR 300 mg/60mL should be avoided to prevent potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.